Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 18c, Revenues Beat Expectations
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Other income (expense): -357K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income (expense): -357K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.59, $0.18 better than the analyst estimate of $0.41. Revenue for the quarter came in at $176.8 million versus the consensus estimate of $174.82 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
